USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biocorp Production S.A.S.

USPTO PatentsView assignee record - 12 granted patents across 7 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Biocorp ranks #22,281 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 7 technology areas.

#22,281
of 49,997 US assignees by volume
Top 44%
by Innovation Score (37.3/100)
15.1
avg claims per patent
+200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22281 · Foreign Corporation #22,281 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 12 grants
  • MID-PACK #22,281/49,997
  • PHOTO-FINISH Bio Pure Technology
  • CPC-NARROW A61M · 7 areas
  • INNOV-THIN 37.3/100
  • CLAIMS-RICH 15.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +200% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bio Pure Technology Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biocorp’s 37.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Biocorp

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Biocorp's Innovation Score is 37.3/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Biocorp?

Each dot is one of Biocorp’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biocorp’s own 15.1 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biocorp vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 020406080 Granted patents (volume) Avg claims / patent Bio Pure Technology Limited - 12, 4Bio Pure Technolo…BioAxone BioSciences, Inc. - 12, 10Bioaxone Bioscien…Biocare Medical, LLC - 12, 13.25Biocare MedicalBiochemtex S.p.A. - 12, 17.17Biochemtex S p ABiogen International Neuroscience GmbH - 12, 58.08Biogen Internatio…Biosphere Aerospace, LLC - 12, 16.58Biosphere Aerospa…Black Horse Off Road of GA, Inc. - 12, 2.08Black Horse Off R…BlackHawk Manufacturing Group, Inc. - 12, 16.17Blackhawk Manufac…Biocorp Production S.A.S. - 12, 15.08Biocorp Productio…
Biocorp vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biocorp's grants concentrate

Biocorp Production S.A.S. is a focused PatentsView assignee: 7 CPC subclasses with 83.3% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2017. By volume, Biocorp sits between Bio Pure Technology Limited and BlackHawk Manufacturing Group, Inc..

Biocorp's three-year grant acceleration

Biocorp Production S.A.S. shows 6 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Biocorp's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Biocorp holds 12 patents at rank #22,301, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Biocorp

By rank, the assignees closest to #22,301 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Biocorp's primary technology class.

Biocorp's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20172018201920202021202220232024 3
USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Biocorp Production S.A.S. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 8.3%
2018 1 8.3%
2019 1 8.3%
2020 2 16.7%
2021 1 8.3%
2022 2 16.7%
2023 1 8.3%
2024 3 25.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Biocorp Production S.A.S.'s patent record in context - here's where to go next.

  • Biocorp Production S.A.S.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 83.3% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #22,281 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Biocorp Production S.A.S. against Bio Pure Technology Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.